An array of pharmaceutical pills with the company's logo on the bottle. “I want to start with a stock that got pummeled today ...

“The problem with the Alzheimer’s group is they were very co-opted,” said Peter J. Whitehouse, MD, PhD, a professor of ...

The series A fundraising is the biggest ever for a European biotech firm, according to the data provider PitchBook.

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...

The company has secured $410m in an oversubscribed Series A funding round, co-led by Forbion and General Atlantic, with contributions from investors such as RA Capital Management, OrbiMed, Logos ...

On 14 November, Eli Lilly became a part of this group, after an account using its name and logo sent out a Tweet ... sparked a direct response by the pharma company to Twitter, requesting that ...

LONDON & SAN FRANCISCO--(BUSINESS WIRE)--Verdiva Bio Limited (“Verdiva” or “the Company”) today announced its launch as a clinical-stage biopharmaceutical company focused on developing ...

Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Omvoh® (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn's ...

In a report released yesterday, Akash Tewari from Jefferies maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a price ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE ... to focus on the growth prospects of certain pharmaceutical stocks while also answering callers’ questions ...